[ST-elevation myocardial infarction: reperfusion strategy based on the results from large clinical trials]

Luigi Inglese1, Cecilia Fantoni

  • 1Divisione di Radiologia Interventistica Cardiovascolare, IRCCS Policlinico San Donato, San Donato Milanese (MI). luigi.inglese@tin.it

Giornale Italiano Di Cardiologia (2006)
|March 23, 2011
PubMed

Insights

Timely reperfusion therapy for ST-elevation myocardial infarction (STEMI) significantly improves outcomes. Early intervention, whether pharmacological or mechanical, maximizes benefits for patient survival and quality of life.

Area of Science:

  • Cardiology
  • Emergency Medicine

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical cardiovascular event.
  • Reperfusion therapy is key to managing STEMI, but its effectiveness is time-sensitive.

Purpose of the Study:

  • To review the time-dependent efficacy of reperfusion strategies in STEMI.
  • To discuss current guidelines and real-world challenges in STEMI management.

Main Methods:

  • Review of clinical guidelines and major trials on STEMI reperfusion.
  • Analysis of time-dependent benefits for pharmacological and mechanical interventions.

Main Results:

  • Reperfusion therapy efficacy is highest when administered early after symptom onset.
  • Pharmacological therapy is effective within 6 hours; primary angioplasty up to 12 hours.
  • Real-world STEMI mortality remains higher than trial data suggests.

Conclusions:

  • Early reperfusion is crucial for myocardial salvage, ventricular function, and long-term survival in STEMI patients.
  • Urgent guideline implementation and revision are needed to address the gap between trial results and real-world outcomes.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...